UB Paderborn / Katalog / Suche / in CDI

1 – 16 von 16

Sortiert nach

Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors

Clinical drug investigation, 2019-07, Vol.39 (7), p.683-690

2019

Volltextzugriff (PDF)

Are educational materials on medicinal products reaching out and useful to physicians? A survey of Singapore prescribers’ experiences and preferences

Proceedings of Singapore healthcare, 2021-09, Vol.30 (3), p.209-217

2021

Volltextzugriff (PDF)

A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore

Pharmacoepidemiology and drug safety, 2022-07, Vol.31 (7), p.729-738

2022

Volltextzugriff (PDF)

Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016

Frontiers in medicine, 2018-06, Vol.5, p.167-167

2018

Volltextzugriff (PDF)

Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore

Vaccine: X, 2023-12, Vol.15, p.100419-100419, Article 100419

2023

Volltextzugriff (PDF)

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

The AAPS journal, 2022-05, Vol.24 (3), p.56-56, Article 56

2022

Volltextzugriff (PDF)

Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based Approach

Drug safety, 2023-10, Vol.46 (10), p.975-989

2023

Volltextzugriff (PDF)

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting

Annals of the Academy of Medicine, Singapore, 2022-02, Vol.51 (2), p.96-100

2022

Volltextzugriff (PDF)

Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

The AAPS journal, 2022-07, Vol.24 (4), p.84-84, Article 84

2022

Volltextzugriff (PDF)

Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore

Drug safety, 2021-09, Vol.44 (9), p.939-948

2021

Volltextzugriff (PDF)

An updated analysis on myocarditis and pericarditis cases reported following mRNA SARS-CoV-2 vaccination in Singapore

Singapore medical journal, 2024-02

2024

Volltextzugriff (PDF)

Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?

Pharmaceutical medicine, 2019-10, Vol.33 (5), p.407-416

2019

Volltextzugriff (PDF)

Registration of similar biological products – Singapore’s approach

Biologicals, 2011-09, Vol.39 (5), p.343-345

2011

Volltextzugriff (PDF)

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting

Annals of the Academy of Medicine, Singapore, 2022-02, Vol.51 (2)

2022

Volltextzugriff (PDF)

Chapter 10 - The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging

Pharmacogenomics, 2013, p.367-404

2013

Volltextzugriff (PDF)

The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging

Pharmacogenomics, 2013, p.367-404

2013

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(14)
Mit Volltextzugriff
(14)

Publikationsform

Artikel
(14)
Buchkapitel
(2)

Sprache

Englisch
(16)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(12)
Science & Technology
(12)
Pharmacology & Pharmacy
(8)
Humans
(6)
Pharmacology/toxicology
(6)
Medicine
(4)
Original Research Article
(4)
Biomedical And Life Sciences
(3)
Biomedicine
(3)
Ethnicity
(3)
Female
(3)
General & Internal Medicine
(3)
Male
(3)
Medicine & Public Health
(3)
Medicine, General & Internal
(3)
Public, Environmental & Occupational Health
(3)
Regulatory Agencies
(3)
Singapore
(3)
Adult
(2)
Algorithms
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors

Are educational materials on medicinal products reaching out and useful to physicians? A survey of Singapore prescribers’ experiences and preferences

A risk classification model for prioritising the management of quality issues relating to substandard medicines in Singapore

Retrospective Study of Reported Adverse Events Due to Complementary Health Products in Singapore From 2010 to 2016

Nationwide safety surveillance of COVID-19 mRNA vaccines following primary series and first booster vaccination in Singapore

International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

Automated Classification of Quality Defect Issues Relating to Substandard Medicines Using a Hybrid Machine Learning and Rule-Based Approach

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting

Correction: International Regulatory Collaboration on the Analysis of Nitrosamines in Metformin-Containing Medicines

Augmenting Product Defect Surveillance Through Web Crawling and Machine Learning in Singapore

An updated analysis on myocarditis and pericarditis cases reported following mRNA SARS-CoV-2 vaccination in Singapore

Ethnicity-Specific Drug Safety Data in European Medicines Agency Registration Dossiers, European Public Assessment Reports, and European and Singapore Drug Labels: Lost in Translation?

Registration of similar biological products – Singapore’s approach

Pericarditis and myocarditis after COVID-19 mRNA vaccination in a nationwide setting

Chapter 10 - The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging

The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging

Suchergebnisse filtern